【摘要】：目的觀察神經(jīng)節(jié)苷酯鈉治療急性重癥顱腦損傷的臨床療效。方法將90例急性重癥顱腦損傷患者隨機(jī)分為對照組45例和試驗組45例。對照組予以靜脈滴注5 mL·kg~(-1)20%甘露醇,30 min完畢+0.4 mg·kg~(-1)呋塞米+納洛酮8 mg+醒腦靜注射液20 mL+注射用血凝酶1 kU,連續(xù)治療8周。試驗組在對照組的基礎(chǔ)上,加用靜脈滴注神經(jīng)節(jié)苷脂鈉注射液100 mg,連續(xù)治療2周后,改為40 mg·d~(-1)維持治療6周。比較2組患者的炎性因子、凝血功能及預(yù)后情況。結(jié)果治療后,試驗組的降鈣素基因相關(guān)肽明顯高于對照組,腫瘤壞死因子、內(nèi)皮素明顯低于對照組(P0.05);試驗組的凝血酶時間明顯低于對照組,纖維蛋白原明顯高于對照組(P0.05),但2組患者的血小板、凝血酶原時間、活化部分凝血酶時間等指標(biāo)比較差異無統(tǒng)計學(xué)意義(P0.05)。試驗組的預(yù)后良好率為46.67%,明顯高于對照組22.22%(P0.05)。結(jié)論神經(jīng)節(jié)苷酯鈉治療急性重癥顱腦損傷有助于緩解炎性癥狀,改善凝血功能,提高臨床療效。
[Abstract]:Objective to observe the clinical effect of ganglioside sodium in the treatment of acute severe craniocerebral injury. Methods 90 patients with acute severe craniocerebral injury were randomly divided into control group (n = 45) and experimental group (n = 45). The control group was given 5 mL kg~ (-1) 20% mannitol intravenously. After 30 min, 0.4 mg kg~ (-1) furosemide 8 mg Xingnaojing injection (20 mL) was injected with hemocoagulase 1 kU, for 8 weeks. On the basis of the control group, the experimental group was treated by intravenous injection of ganglioside sodium injection for 2 weeks, then changed to 40 mg D1 for 6 weeks. The inflammatory factors, coagulation function and prognosis of the two groups were compared. Results after treatment, calcitonin gene-related peptide in the experimental group was significantly higher than that in the control group, tumor necrosis factor and endothelin were significantly lower than those in the control group (P0.05). The thrombin time and fibrinogen in the experimental group were significantly lower than those in the control group (P0.05), but the platelet and prothrombin time of the two groups were significantly higher than that of the control group (P0.05). There was no significant difference in activated partial thrombin time (P0.05). The good prognosis rate of the trial group was 46.67, significantly higher than that of the control group 22.22% (P0.05). Conclusion ganglioside sodium can relieve inflammatory symptoms, improve coagulation function and improve clinical efficacy in patients with acute severe craniocerebral injury.
【作者單位】： 遵義醫(yī)學(xué)院附屬醫(yī)院神經(jīng)外科;遵義醫(yī)學(xué)院附屬醫(yī)院護(hù)理部;
【基金】：貴州省科學(xué)技術(shù)基金資助項目(黔科合J字【2013】2330號)
【分類號】：R651.15

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 林耘;神經(jīng)節(jié)苷酯治療新生兒缺氧缺血性腦病68例[J];航空航天醫(yī)藥;2005年01期

2 李士玉;李雷;馬玉玲;;神經(jīng)節(jié)苷酯對急性一氧化碳中毒患者腦功能的影響[J];濟(jì)寧醫(yī)學(xué)院學(xué)報;2009年02期

3 劉亞玲;鄭雯;;神經(jīng)節(jié)苷酯治療新生兒缺氧缺血性腦病臨床分析[J];中國實用神經(jīng)疾病雜志;2009年17期

4 李旭斌;張賢;劉紅龍;;神經(jīng)節(jié)苷酯聯(lián)合高壓氧治療新生兒缺氧缺血性腦病[J];基層醫(yī)學(xué)論壇;2009年S1期

5 古玉芳;;神經(jīng)節(jié)苷酯鈉聯(lián)合高壓氧治療新生兒缺氧缺血性腦病49例[J];右江醫(yī)學(xué);2010年04期

6 王樹國;;硫酸鎂加神經(jīng)節(jié)苷酯治療新生兒缺氧缺血性腦病的療效觀察[J];實用醫(yī)學(xué)雜志;2011年02期

7 柳運(yùn)盛;盧宗會;;神經(jīng)節(jié)苷酯輔助治療新生兒缺氧缺血性腦病的臨床療效觀察[J];當(dāng)代醫(yī)學(xué);2011年04期

8 楊盛賢;;神經(jīng)節(jié)苷酯治療特發(fā)性面神經(jīng)麻痹的療效觀察[J];內(nèi)科;2012年06期

9 張秀茹;;神經(jīng)節(jié)苷酯注射液治療新生兒缺氧缺血性腦病的療效[J];中國實用神經(jīng)疾病雜志;2013年10期

10 張勇;;神經(jīng)節(jié)苷酯治療新生兒缺氧缺血性腦病的臨床分析[J];中國繼續(xù)醫(yī)學(xué)教育;2013年04期

相關(guān)會議論文 前2條

1 朱斌;;神經(jīng)節(jié)苷酯聯(lián)合丙種球蛋白治療小兒重癥病毒性腦炎療效觀察[A];中華醫(yī)學(xué)會第十七次全國兒科學(xué)術(shù)大會論文匯編（下冊）[C];2012年

2 周慧萍;吳春美;杜小鵬;;單唾液酸四己糖神經(jīng)節(jié)苷酯治療腦梗死臨床療效觀察[A];新醫(yī)藥衛(wèi)生改革與藥學(xué)發(fā)展高峰論壇暨《中國藥學(xué)雜志》第十二屆編委會會議論文集[C];2009年

相關(guān)碩士學(xué)位論文 前1條

1 李紅梅;神經(jīng)節(jié)苷酯對實驗性腦出血腦細(xì)胞凋亡相關(guān)蛋白表達(dá)的影響[D];瀘州醫(yī)學(xué)院;2013年

，

本文編號：2409285